Physician
Cardiology
Dr. James B. Hermiller, MD
|
|
Give Review
James Hermiller works in the field of Cardiology. He studied medicine at The Ohio State University College of Medicine. He received 1 awards: "Fellow (FACC)". James Hermiller is also a published MD. He has 36 paper published. The most recent paper is: A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients. He accepts all Medicare patients.
Publications
- A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- Clinical outcomes in the percutaneous Coronary intervention of in-stent restenosis with everolimus-eluting stents.
- Transcatheter Aortic valve replacement using a self-expanding bioprosthesis in patients with severe Aortic stenosis at extreme risk for surgery.
- On-line application of near-infrared spectroscopy for monitoring water levels in parts per million in a manufacturing-scale distillation process.
- Clinical outcomes in real-world patients with small vessel Disease treated with XIENCE V® Everolimus-Eluting Stents: one year results from the XIENCE V® USA condition ...
- Five-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents: Final Results From the SPIRIT III Trial.
- Clinical outcomes in real-world patients with Acute myocardial infarction receiving XIENCE V(®) everolimus-eluting stents: One-year results from the XIENCE V USA study.
- Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease: Final 3-Year Results of the SPIRIT Clinical Trials Program (Clinical E...
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous Coronary intervention (PARIS): 2 year results from a prospective observational study.
- 4-year results of a randomized controlled trial of percutaneous repair versus surgery for Mitral regurgitation.
- A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-mark...
- Performance of Everolimus-Eluting versus Paclitaxel-Eluting Coronary Stents in Small Vessels: Results from the SPIRIT III and SPIRIT IV Clinical Trials.
- A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in Coronary arte...
- Presentation and therapy of spontaneous Coronary artery dissection and comparisons of postpartum versus nonpostpartum cases.
- Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).
- Three-year results of safety and efficacy of the everolimus-eluting Coronary stent in women (from the SPIRIT III randomized clinical trial).
- Comparison of everolimus-eluting and paclitaxel-eluting Coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Eva...
- The unrelenting challenge of vein graft Disease.
- Clinical and angiographic outcomes with an everolimus-eluting stent in large Coronary arteries: the SPIRIT III 4.0 mm registry.
- Contemporary bifurcation treatment strategies: the role of currently available slotted tube stents.
- A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after Acute myocardial infarction.
- Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small Coronary arteries: a post hoc analysis of the SPIRIT III randomized t...
- Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting ...
- Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.
- Bifurcation Coronary artery disease: current techniques and future directions (part 2).
- Bifurcation Coronary artery disease: current techniques and future directions (part 1).
- Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial Disease.
- Bifurcation intervention: keep it simple.
- Post-stent very proximal left anterior descending Coronary artery aneurysm.
- Contemporary treatment of small-vessel Disease.
- Feasibility of endovascular cooling as an adjunct to primary percutaneous Coronary intervention (results of the LOWTEMP pilot study).
- Role of enoxaparin in the invasive management of the ACS patient.
- Coarctation of the aorta in an adult: problems of diagnosis and management.
- Risk factors for Coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.
Schools
Ohio State University College Of Medicine and Public Health
National Naval Medical Center
Duke University Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Duke University Hospital -
National Capital Consortium -
The Ohio State University College of Medicine
Hospital
-
St. Vincent Indianapolis Hospital -
Hendricks Regional Health
Drug Facts
| NPI NUMBER | 1619943263 | |
| NPPES Provider LastName | HERMILLER | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 462901028 | |
| NPPES Provider State | IN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 3139.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619943263 |
| Last Name Of The Provider | HERMILLER |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Kirk L. Parr, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Storer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bertram A. Graves, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Scozzaro, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nancy A. Branyas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Adlam, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John D. Graham III, MD |
|
|
Dr. Joe A. Ware, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. August Watanabe, MD
This Doctor is OpenDoctor Recommended.
|